Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.

Abstract

PURPOSE A randomized trial of chemotherapy, given on either a 1-week or a 3-week schedule, was performed in small-cell lung cancer (SCLC) patients. The aim was to determine if weekly scheduling produced survival superior to conventional treatment. PATIENTS AND METHODS Four hundred thirty-eight patients with SCLC with either limited disease (LD; 276… (More)

Topics

Cite this paper

@article{Souhami1994RandomizedTC, title={Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.}, author={Robert L. Souhami and R. E. Rudd and Mary Carmen Ruiz de Elvira and Lynwen James and Nicole H Gower and P. G. Harper and Jeffrey S. Tobias and Martyn Partridge and A. G. Davison and Colin W Trask}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={1994}, volume={12 9}, pages={1806-13} }